Decoupling the role of RORgt in the differentiation and effector function of Th17 cells. Decoupling the role of RORgt in the differentiation and effector function of Th17 cells

RORgt is known to instruct the differentiation of Th17 cells that mediate the pathogenesis of autoimmune diseases. However, it remains unknown whether RORgt plays a distinct role in the differentiation and effector function of Th17 cells. Here we show that mutation of RORgt lysine 256, a ubiquitination site, to arginine (K256R) separates the RORgt role in these two functions. Preventing ubiquitination at K256 via arginine substitution does not affect RORgt-dependent thymocyte development and Th17 differentiation in vitro and in vivo, however, greatly impaired the pathogenesis of Th17 cell-mediated experimental autoimmune encephalomyelitis (EAE). Mechanistically, K256R mutation impairs RORgt to bind to and activate Runx1 expression critical for Th17-mediated EAE. Thus, RORgt regulates the effector function of Th17 cells in addition to Th17 differentiation. This work informs the development of RORgt-based therapies that specifically target the effector function of Th17 cells responsible for autoimmunity. Overall design: Comparitive gene expression profiling analysis of RNA-Seq data for sorted (EGFP+) WT/IL-17A-EGFP and RORγt-K256R/IL-17A-EGFP mouse CD4+ T cells in vitro differentiated under Th17 polarization condition